Does interleukin-21 gene transfection into mouse bladder cancer cells result in tumor rejection through the cytotoxic T lymphocyte response?
Interleukin-21 production in situ elicits antitumor activity through the activation of CD8+ T cells in vivo.
Vascular endothelial growth factor/sVEGF-1 ratio is an independent prognostic factor for survival in pancreatic cancer. Its significance should be assessed when considering antiangiogenic therapy in treating pancreatic cancer patients.